Angiodynamics submits 510(k) application to fda for alphavac mechanical thrombectomy system

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology today announced that on april 9, 2021, it submitted a 510(k) application to the united states food and drug administration (fda) for the alphavac system, an off-circuit, multi-purpose mechanical aspiration thrombectomy device for the treatment of undesirable intravascular material in the venous syst
ANGO Ratings Summary
ANGO Quant Ranking